Understanding DNA starting material for mRNA production
Year: 2024
Type: article
Abstract: Charlotte Barker, Commissioning Editor, Vaccine Insights, speaks to Lawrence Thompson, Associate Research Fellow, Pfizer, about advances and challenges in DNA starting materials for mRNA vaccine production, including gaps in guidance, the growing role of synthetic DNA starting material, and the transition of next-generation sequencing techniques into GMP environments.
Source: Vaccine Insights
Author: Lawrence Thompson
Institution: Pfizer (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4417357206
FWCI:
Cites:
Cited by:
Related to: